Clinical News

Median gets CE marking for lung cancer screening software
By AuntMinnie.com staff writers
The CE marking follows the U.S. Food and Drug Administration (FDA)'s 510(k) clearance of eyonis LCS in February.
July 6, 2026
Lung Cancer
99% wasn't enough: How persistence in imaging changes the picture
By Claudia Tschabuschnig
Two patient stories told at the European Parliament proved that a second look can change everything.
July 6, 2026
European Parliament, Brussels. Policymakers, clinicians, and patient representatives at the 'Imaging Saves Lives' event, July 2.
PET/MRI can reduce the need for biopsies in prostate cancer
By Will Morton
Prostate biopsies are associated with considerable morbidity, including pain, rectal bleeding, prostatitis, and urinary tract infections.
July 2, 2026
A visual abstract of the study.
Quibim launches AI breast MRI tool across Europe, UK
By AuntMinnieEurope.com staff writers
The tool, QP-Breast, highlights suspicious areas on MRI and generates reports from imaging findings.
July 2, 2026
Qp Breast Press 02
Imaging takes center stage in Europe's Safe Hearts Plan
By Claudia Tschabuschnig
Radiology and nuclear medicine are poised to play a central role in implementing the European Commission's Safe Hearts Plan, speakers said during a joint ESR/EANM event in Brussels.
July 2, 2026
The Safe Hearts Plan aims to shift healthcare systems toward prevention, earlier diagnosis, and more personalized care.
AuntMinnieEurope.com CT Insider
By Claudia Tschabuschnig
This Insider tracks the muscle hiding in plain sight on coronary CT, the guesswork still baked into contrast agent safety, and Germany's screening rollout hitting real-world friction.
July 1, 2026
GE HealthCare, University Hospital Essen open nuclear medicine center
By AuntMinnieEurope.com staff writers
The center features the first installation of GE HealthCare's StarGuide GX SPECT/CT scanner.
July 1, 2026
Ge
Can side-chain chemistry help radiologists choose a safer contrast agent after a hypersensitivity reaction?
By Claudia Tschabuschnig
Choosing an alternative contrast agent after an allergic reaction often falls to clinical judgment. A new review examines whether side-chain chemistry can make that decision a little more evidence based.
July 1, 2026
Dr. Aart J. van der Molen, of Leiden University Medical Center in Leiden, the Netherlands, is the lead author of a review exploring side-chain chemistry as a guide for selecting alternative iodine-based contrast media.
Low muscle density on coronary CT linked to heart risk
By Will Morton
Patients with skeletal muscle attenuation below the median had a higher risk of mortality and myocardial infarction.
June 30, 2026
An example of machine learning–based multiorgan body composition assessment (TotalSegmentator V2.0.4, 1.5-mm high-resolution model) in a 63-year-old man with obstructive coronary artery disease and a skeletal muscle attenuation below the median. (A) Transverse, (B) coronal, and (C) sagittal CT images and curved planar reformations of the (D) left, (E) circumflex, and (F) right coronary arteries.
Medneo acquires Ramsay Diagnostics UK mobile imaging fleet
By AuntMinnieEurope.com staff writers
Medneo is acquiring Ramsay Diagnostics UK's mobile MRI and CT fleet and a six-year contract to provide mobile imaging services.
June 30, 2026
Mri Scanner2 400
Ratio Therapeutics signs Ac-225 supply agreement with PanTera
By AuntMinnie.com staff writers
Deal will support Ratio's alpha therapy programs.
June 30, 2026
Business Deal Corporate 400
GE HealthCare offers upgrades for interventional systems
By AuntMinnie.com staff writers
Upgraded systems also qualify for GE HealthCare's Tube Watch and OnWatch Predict service options.
June 29, 2026
Ai Logo
Page 1 of 1326
Next Page